Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection-Reference-Cited by-同舟云学术

Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection

Published:2019-04-11 Issue:5 Volume:32 Page:763-773
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Coppola Nicola^ORCID,Portunato Federica,Buonomo Antonio Riccardo,Staiano Laura,Scotto Riccardo,Pinchera Biagio,De Pascalis Stefania,Amoruso Daniela Caterina,Martini Salvatore,Pisaturo Mariantonietta,Coppola Carmine,Gentile Ivan

Funder

Campania Univeristy

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-019-00608-z.pdf

Reference31 articles.

1. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61(1 Suppl):S45–S57

2. Negro F, Forton D, Craxì A et al (2015) Extra-hepatic morbidity and mortality of chronic hepatitis C. Gastroenterology 149:1345–1360

3. Gill K, Ghazinian H, Manch R et al (2016) Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int 10:415–423

4. Latt N, Alachkar N, Gurakar A (2012) Hepatitis C virus and its renal manifestations: a review and update. Gastroenterol Hepatol 8:434–445

5. Gentile I, Coppola N, Buonomo AR et al (2014) Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus. Expert Opin Investig Drugs 23(9):1211–1223

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus infection is associated with high risk of breast cancer: a pooled analysis of 68,014 participants;Frontiers in Oncology;2023-10-13

2. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy;Gastroenterología y Hepatología (English Edition);2023-10

3. Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection;HIV/AIDS - Research and Palliative Care;2023-02

4. Microbiota and hepatitis C virus in the era of direct-acting antiviral agents;Microbial Pathogenesis;2023-02

5. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C;Gastroenterología y Hepatología;2023-01